3 international workshop on clinical pharmacology...
TRANSCRIPT
Dear colleagues,
We are pleased to announce the 3rd International Workshop on Clinical Pharmacology of Anticancer Drugs, is scheduled to take place on 8-9 November 2018 in Amsterdam, the Netherlands.
The field of anticancer drugs is in continuous development. Given the many existing drugs with multiple unanswered pharmacological questions and with the introduction of the new group of agents with their unique pharmacological properties many studies are being performed which will lead to new perspectives. This meeting offers a platform for indepth discussion and debate among experts on new data and their implications.
We invite you to attend the International Workshop on Clinical Pharmacology of Anticancer Drugs in Amsterdam.
We look forward to greeting you.Organizing Committee
Etienne ChatelutPharmD, PhD University Institute Cancer Toulouse Oncopole, France
Maria J. GarridoPhD University of Navarra, Spain
George DemetriMD Harvard Medical School, USA
Howard GurneyMBBS, FRACP Westmead Hospital, Australia
Nielka van ErpPharmD, PhD Radboud University Medical Centre, the Netherlands
Ron MathijssenMD, PhD Erasmus Medical Centre, the Netherlands
Lena FribergPhD Uppsala University, Sweden
Michelle RudekPharmD, PhD Johns Hopkins University, USA
3RD INTERNATIONAL WORKSHOP ON
AMSTERDAM, THE NETHERLANDS • 8 - 9 NOVEMBER 2018
CLINICAL PHARMACOLOGY OF ANTICANCER DRUGS
expertmedical events
THIS MEETING IS ORGANIZED BY:
www.expertmedicalevents.com
REVISIT THE 2017 EDITION
Want to see more? Visit Infectious Diseases Online: infectiousdiseasesonline.comGain access to all the meeting presentations, webcasts, abstracts, and more!
WHO SHOULD ATTEND?
Medical oncologists, internal medicine doctors, clinical pharmacologists, hospital pharmacists, industry researchers, government representatives and other experts involved in this field of research.
ORGANIZING COMMITTEE
MEETING OBJECTIVES
• To gather professionals in the field of pharmacology of anticancer drugs in an interactive workshop setting;
• To provide a platform for presentation and discussion of the latest pharmacological developments in the field;
• To map current studies and latest results;
• To translate new data into treatment opportunities;
• To educate clinicians on pharmacological challenges that need to be addressed with the implementation of current and new drugs.
expertmedical events www.expertmedicalevents.com
MORE INFORMATION
Abstract submission is open until 1 September
Complimentary registration for young investigators with an accepted abstract.
ABSTRACT TOPICS
• Pharmacokinetics and pharmacodynamics of anticancer drugs
• Population pharmacokinetics & pharmacokinetic-pharmacodynamic modeling
• Drug development and optimization: approaches & tools
• Drug-drug and drug-disease state interactions
• Anticancer drug therapies in special populations
Registration is openEarly registration discount is available until 7 March.
ENDORSERS
Members of endorsing organizations enjoy addtional 25% discount on registration fees.
SPONSORS
Contributor level
Session topics:• Pharmacological challenges of immunotherapeutics
• Combination therapy – old school is becoming new school again
• Dose individualization approaches
• Drug-Drug / Drug-Food / Drug-Environmental interactions
• Approaches to shorten phase II studies by the use of different read out endpoints
• PK/PD studies and new strategies